CD200 receptor controls sex-specific TLR7 responses to viral infection

Prof. Linde Meyaard

Professor of Immune Regulation, Laboratory of Translational Immunology, University Medical Center Utrecht, The Netherlands

im Ferdinand-Bergen-Auditorium des HPI

Role of type I IFN in the establishment of CMV latency

Prof. Luka Cicin-Sain

Helmholtz Center for Infection Research, Braunschweig

im Ferdinand-Bergen-Auditorium des HPI

Human Cytomegalovirus encodes two complementary Beclin 1-interacting anti-autophagic proteins

Prof. Audrey Esclatine

Inserm UMR 984, Faculté de Pharmacie, Chatenay-Malabry, France

im Ferdinand-Bergen-Auditorium des HPI

The LMP1 oncoprotein of Epstein-Barr virus: from signaling mechanisms to therapeutic target

PD Dr. Arnd Kieser

Arbeitsgruppe Signaltransduktion, Abteilung Genvektoren, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt

im Ferdinand-Bergen-Auditorium des HPI

Control of HIV by natural and vaccine-induced CD8+ T cell responses in BLT humanized mice

Prof. Todd M. Allen

Harvard Medical School, Ragon Institute of MGH, MIT and Harvard Massachusetts General Hospital, Cambridge, USA

im Ferdinand-Bergen-Auditorium des HPI

Mx GTPases: Antiviral Effector Proteins of the Interferon System

Prof. Otto Haller

Institute of Virology, University Medical Center Freiburg, Germany

im Ferdinand-Bergen-Auditorium des HPI

Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome in children and adults

Dr. Anita McElroy

Centers for Disease Control and Prevention, Atlanta, USA

im Ferdinand-Bergen-Auditorium des HPI

How SUMO talks to Ubiquitin

Prof. Ronald T. Hay

Centre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, United Kingdom

im Ferdinand-Bergen-Auditorium des HPI

Immune control of HCV in highly exposed people who inject drugs

Prof. Jörg Timm

Universitätsklinikum Essen, Universität Duisburg-Essen, Institut für Virologie

im Ferdinand-Bergen-Auditorium des HPI

Roadblocks in the design of an effective HIV vaccine

Prof. Christian Brander

im Ferdinand-Bergen-Auditorium des HPI